AbbVie Mock Interview
Practice 35 AbbVie interview questions covering scientific knowledge, patient impact, and biopharmaceutical innovation.
Question 4 of 35
What industry related changes do you foresee in the next 12 months?
How to Answer
Example Answer
Example Answer 2
Community Answers
Kimberly is a freelance writer and editor with a decade of experience in the education field, including her time as a pre-kindergarten teacher.
Assure the interviewer that you have a keen and honest interest in this industry by discussing the growth and change that you foresee in this next year. If the organization has any upcoming news or changes, be sure to mention these as well.
Krista Wenz has been on thousands of interview panels hiring EMS professionals and firefighters for public and private agencies.
"I read on your website that AbbVie is expected to see a 43% increase in the sales of product ABC. This fact piqued my interest as I have seen reports that forecast a strong increase in the use of product ABC for alternative medical therapies. There are continual changes in this industry, but I see this particular one being very significant in the upcoming months."
Kimberly is a freelance writer and editor with a decade of experience in the education field, including her time as a pre-kindergarten teacher.
"I recently read an article by Q1 Productions that addressed this exact topic. They mentioned in the article that 2018 is going to be a great year for the pharma industry due to the economic upturn. The thought is that this will increase stock prices, thus allowing pharma companies to grow their offerings, expand operations, and further their research and reach. It's an exciting thought!"
Interview Coach
Jaymie
A real coach, not AI. I read every answer myself and write back with personalized feedback.
Typically responds within 24 hours.
0 - Character Count
Anonymous Answer
Well, there are three perspectives, first change from the regulations perceptive, which I think won't be too aggressive in the next 12 months. Regulatory bodies are already doing a great job of keeping the benchmarks high for pharmaceutical companies. Second is approvals of many breakthrough life-saving drugs and biosimilars in the next 12 months will be high. The third is possible acquisitions in the industries as a good number of large companies are trying to consolidate the businesses across the globe.
Rachelle's Feedback
It's fantastic that you take three angles here, truly showcasing the depth of your knowledge in the pharma business. Very well done!
Unlock All 35 AbbVie Questions
Unlock expert responses that demonstrate commitment to advancing patient care and scientific excellence.
Get StartedJump to Question